Cargando…
Neuroprotective Effects of gH625-lipoPACAP in an In Vitro Fluid Dynamic Model of Parkinson’s Disease
Parkinson’s disease (PD) is an aggressive and devastating age-related disorder. Although the causes are still unclear, several factors, including genetic and environmental, are involved. Except for symptomatic drugs, there are not, to date, any real cures for PD. For this purpose, it is necessary de...
Autores principales: | Barra, Teresa, Falanga, Annarita, Bellavita, Rosa, Pisano, Jessica, Laforgia, Vincenza, Prisco, Marina, Galdiero, Stefania, Valiante, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599564/ https://www.ncbi.nlm.nih.gov/pubmed/36289905 http://dx.doi.org/10.3390/biomedicines10102644 |
Ejemplares similares
-
gH625-liposomes deliver PACAP through a dynamic in vitro model of the blood–brain barrier
por: Barra, Teresa, et al.
Publicado: (2022) -
gH625-liposomes as tool for pituitary adenylate cyclase-activating polypeptide brain delivery
por: Iachetta, Giuseppina, et al.
Publicado: (2019) -
Dimerization in tailoring uptake efficacy of the HSV-1 derived membranotropic peptide gH625
por: Falanga, Annarita, et al.
Publicado: (2017) -
gH625: A milestone in understanding the many roles of membranotropic peptides
por: Galdiero, Stefania, et al.
Publicado: (2015) -
Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood–brain barrier in rats
por: Valiante, Salvatore, et al.
Publicado: (2015)